Get the Stockscreener App
9.68
5.00%
-0.51
After Hours:
9.68
Immatics N V stock is traded at $9.68, with a volume of 798.09K.
It is down -5.00% in the last 24 hours and up +2.98% over the past month.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$10.19
Open:
$10.02
24h Volume:
798.09K
Relative Volume:
0.94
Market Cap:
$1.18B
Revenue:
$58.49M
Net Income/Loss:
$-105.04M
P/E Ratio:
-7.4479
EPS:
-1.2997
Net Cash Flow:
$-13.78M
1W Performance:
-8.51%
1M Performance:
+2.98%
6M Performance:
+85.09%
1Y Performance:
+3.75%
1-Day Range:
$9.50
$10.34
1-Week Range:
$9.50
$10.72
52-Week Range:
$3.30
$11.25
Immatics N V Stock (IMTX) Company Profile
Compare IMTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
9.68 | 1.24B | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Guggenheim | Buy |
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
Applying Elliott Wave Theory to Immatics N.V.Weekly Loss Report & Reliable Intraday Trade Plans - newser.com
Why Immatics N.V. stock is a must watch in 2025Market Performance Summary & Proven Capital Preservation Tips - newser.com
Heatmap analysis for Immatics N.V. and competitorsWeekly Trade Summary & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-03 07:36:49 - newser.com
Has Immatics N.V. Equity Warrant formed a bullish divergenceMarket Growth Review & Free Reliable Trade Execution Plans - newser.com
Can Immatics N.V. stock hit analyst price targetsQuarterly Profit Summary & AI Enhanced Trade Execution Alerts - newser.com
Is Immatics N.V. Equity Warrant reversing from oversold territoryJuly 2025 Outlook & Stepwise Trade Signal Implementation - newser.com
Will Immatics N.V. stock beat EPS estimatesRisk Management & Weekly Setup with ROI Potential - newser.com
What analyst consensus says on Immatics N.V. stockWeekly Risk Report & AI Forecast for Swing Trade Picks - newser.com
How Immatics N.V. (4A3) stock reacts to monetary easing2025 Market Overview & Weekly High Return Opportunities - newser.com
Can Immatics N.V. stock rebound after recent weaknessQuarterly Profit Review & Daily Growth Stock Investment Tips - newser.com
Developing predictive dashboards with Immatics N.V. Equity Warrant dataJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - newser.com
Volatility clustering patterns for Immatics N.V. Equity WarrantM&A Rumor & Real-Time Volume Trigger Notifications - newser.com
Leading vs lagging indicators on Immatics N.V. performance2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Analyzing Immatics N.V. with multi timeframe charts2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Why Immatics N.V. (4A3) stock appeals to dividend investorsStop Loss & Accurate Trade Setup Notifications - newser.com
How to build a custom watchlist for Immatics N.V. Equity WarrantDip Buying & Long-Term Capital Growth Strategies - newser.com
Chart based analysis of Immatics N.V. Equity Warrant trendsJuly 2025 Price Swings & High Win Rate Trade Tips - newser.com
How to track smart money flows in Immatics N.V.Earnings Growth Summary & Free Community Supported Trade Ideas - newser.com
Is a relief rally coming for Immatics N.V. holdersJuly 2025 Selloffs & Verified Entry Point Detection - newser.com
Can Immatics N.V. Equity Warrant hit a new high this monthDollar Strength & Weekly Stock Performance Updates - newser.com
Published on: 2025-11-02 12:20:51 - newser.com
How Immatics N.V. stock responds to policy changesWeekly Trade Recap & Fast Moving Market Watchlists - newser.com
Published on: 2025-11-02 06:36:48 - newser.com
Published on: 2025-11-02 06:21:14 - newser.com
Order flow analysis tools used on Immatics N.V.July 2025 Market Mood & AI Based Buy/Sell Signal Reports - newser.com
Published on: 2025-11-02 03:46:01 - newser.com
How resilient is Immatics N.V. Equity Warrant stock in market downturns2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com
Will Immatics N.V. stock reach all time highs in 2025Options Play & Daily Growth Stock Tips - newser.com
Candlestick signals on Immatics N.V. stock todayWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Is Immatics N.V. Equity Warrant stock positioned for long term growthWeekly Profit Recap & Verified Trade Idea Suggestions - newser.com
Will Immatics N.V. stock outperform Dow Jones indexTrade Ideas & Weekly High Momentum Picks - newser.com
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):